FIELD: medicine, gynecology.
SUBSTANCE: invention relates to a method for treatment of uterus myoma. Method involves carrying out the selective catheterization and the following administration of actovegin in the dose 100 mg in 2.5 ml into both uterus arteries followed by immediate administration of embolyzate. Method provides the painless course of post-embolization period and decreasing symptoms of post-embolization syndrome.
EFFECT: improved method of treatment.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF CONSERVATIVE MYOMECTOMY IN PREGNANT WOMEN | 2015 |
|
RU2606494C1 |
| METHOD FOR TRANSRADIAL ENDOVASCULAR EMBOLISATION OF UTERINE ARTERIES | 2014 |
|
RU2551947C1 |
| PREVENTION METHOD FOR POSTOPERATIVE COMPLICATIONS INVOLVING EMBOLISED UTERINE ARTERIES IN UTERUS MYOMAS | 2008 |
|
RU2364335C1 |
| METHOD FOR PREDICTION OF HYSTEROMYOMA REGRESSION | 2015 |
|
RU2596093C1 |
| METHOD FOR DETERMINING NON-TARGET UTERINE ARTERY EMBOLIZATION | 2021 |
|
RU2768142C1 |
| METHOD FOR PREDICTION OF SEVERE POST-EMBOLIZATION SYNDROME IN PATIENT WITH UTERINE MYOMA IN EARLY POSTOPERATIVE PERIOD | 2019 |
|
RU2729183C1 |
| METHOD FOR INTEGRATED TREATMENT OF CERVICAL PREGNANCY | 2013 |
|
RU2514548C1 |
| METHOD FOR PREDICTION OF ENDOMETRIAL HYPERPLASIA IN PATIENTS WITH HYSTEROMYOMA FOLLOWING UTERINE ARTERY EMBOLISATION | 2014 |
|
RU2558052C1 |
| METHOD FOR COMBINED TREATMENT OF UTERINE MYOMAS | 2019 |
|
RU2730926C1 |
| METHOD FOR SELECTIVE CATHETERISATION AND EMBOLISATION OF UMBILICAL ARTERIES FOR TREATING PATIENTS WITH UTERINE FIBROID OR UTERINE BLEEDING | 2014 |
|
RU2550006C1 |
